Eur J Endocrinol
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


DOI: 10.1530/eje.0.1300547
European Journal of Endocrinology, Vol 130, Issue 6, 547-551
Copyright © 1994 by European Society of Endocrinology
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chaouki, M. L
Right arrow Articles by Benmiloud, M.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Chaouki, M. L
Right arrow Articles by Benmiloud, M.

Prevention of iodine deficiency disorders by oral administration of lipiodol during pregnancy

Mohamed L Chaouki and Moulay Benmiloud

Chaouki ML. Benmiloud M. Prevention of iodine deficiency disorders by oral administration of lipiodol during pregnancy. Eur J Endocrinol 1994;130:547–51. ISSN 0804–4643

The prevalence of iodine deficiency disorders and the thyroid status of the population were studied in an endemic goitre area in Algeria. After oral administration of lipiodol (0.5 ml), three treated groups of mother–newborn couples were compared to an untreated group: group A, mothers treated 1–3 months before conception; group B, mothers treated during the first month of pregnancy; group C, mothers treated during the third month of pregnancy. Untreated mothers were used as a control (group D). After lipiodol treatment, all newborn babies and mothers were clinically euthyroid. All tested newborn babies were full term and no goitre was observed in the four groups. In the mothers, goitre prevalence and thyrotrophin levels decreased significantly, whereas maternal milk and urinary iodine and serum-free thyroxine levels were significantly higher after treatment. The rate of prematurity, stillbirths and abortions in the treated groups was reduced when compared to the untreated group, whereas placental and birth weights were significantly higher. In group D two cases of neonatal hypothyroidism were detected. Their re-evaluation confirmed that hypothyroidism was transient. Groups A, B and C were statistically different from group D with regard to neonatal thyrotrophin and thyroxine. Positive correlations were found between neonatal thyroxine and birth weights and placental weights on the one hand, and maternal urinary iodine and free thyroxine on the other. Consequently, these data indicate that oral administration of lipiodol before or during the first trimester of pregnancy normalizes thyroid function in newborn babies and mothers, increases placental and birth weight and reduces the frequency of iodine deficiency disorders. Lipiodol at this dose and during the first trimester of pregnancy had no deleterious effects and may prevent hypothyroid or neurological cretinism.

Mohamed Lamine Chaouki, Service d'Endocrinologie, Centre Hospitalo-Universitaire de Batna, Route de Tazoult 05000, Batna, Algeria




This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
Subsection Reports
J. Clin. Endocrinol. Metab., August 1, 2007; 92(8_suppl): s8 - s47.
[Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
M. Abalovich, N. Amino, L. A. Barbour, R. H. Cobin, L. J. De Groot, D. Glinoer, S. J. Mandel, and A. Stagnaro-Green
Management of Thyroid Dysfunction during Pregnancy and Postpartum: An Endocrine Society Clinical Practice Guideline
J. Clin. Endocrinol. Metab., August 1, 2007; 92(8_suppl): s1 - s47.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
M. B. Zimmermann, P. L. Jooste, N. S. Mabapa, X. Mbhenyane, S. Schoeman, R. Biebinger, N. Chaouki, M. Bozo, L. Grimci, and J. Bridson
Treatment of Iodine Deficiency in School-Age Children Increases Insulin-Like Growth Factor (IGF)-I and IGF Binding Protein-3 Concentrations and Improves Somatic Growth
J. Clin. Endocrinol. Metab., February 1, 2007; 92(2): 437 - 442.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
C. H.D. Fall, C. S. Yajnik, S. Rao, A. A. Davies, N. Brown, and H. J.W. Farrant
Micronutrients and Fetal Growth
J. Nutr., May 1, 2003; 133(5): 1747S - 1756.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
A. M. d. L. Costello and D. Osrin
Micronutrient Status during Pregnancy and Outcomes for Newborn Infants in Developing Countries
J. Nutr., May 1, 2003; 133(5): 1757S - 1764.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
D. Glinoer
The Regulation of Thyroid Function in Pregnancy: Pathways of Endocrine Adaptation from Physiology to Pathology
Endocr. Rev., June 1, 1997; 18(3): 404 - 433.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
F. Aghini-Lombardi, L. Antonangeli, A. Pinchera, F. Leoli, T. Rago, A. M. Bartolomei, and P. Vitti
Effect of Iodized Salt on Thyroid Volume of Children Living in an Area Previously Characterized by Moderate Iodine Deficiency
J. Clin. Endocrinol. Metab., April 1, 1997; 82(4): 1136 - 1139.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
C. Cobra, Muhilal, K. Rusmil, D. Rustama, Djatnika, S. S. Suwardi, D. Permaesih, Muherdiyantiningsih, S. Martuti, and R. D. Semba
Infant Survival Is Improved by Oral Iodine Supplementation
J. Nutr., April 1, 1997; 127(4): 574 - 578.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1994 European Society of Endocrinology.